Credit Suisse Ag Eagle Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$17.74 - $31.87 $9,881 - $17,751	557 Added 4.3%	13,514 $262,000
Q1 2023 May 10, 2023	BUY	$25.06 - $34.09 $27,390 - $37,260	1,093 Added 9.21%	12,957 $367,000
Q4 2022 Feb 13, 2023	BUY	$24.98 - $39.77 $80,010 - $127,383	3,203 Added 36.98%	11,864 $346,000
Q3 2022 Nov 10, 2022	BUY	$26.42 - $47.12 $4,068 - $7,256	154 Added 1.81%	8,661 $229,000
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $14,729 - $18,331	-357 Reduced 4.03%	8,507 $378,000
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $7,756 - $9,152	174 Added 2.0%	8,864 $439,000
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $4,627 - $5,746	101 Added 1.18%	8,690 $443,000
Q3 2021 Nov 12, 2021	SELL	$43.79 - $55.78 $62,050 - $79,040	-1,417 Reduced 14.16%	8,589 $480,000
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $4,828 - $5,829	-131 Reduced 1.29%	10,006 $428,000
Q1 2021 May 14, 2021	SELL	$40.32 - $50.97 $374,855 - $473,868	-9,297 Reduced 47.84%	10,137 $424,000
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $226,164 - $278,314	-5,421 Reduced 21.81%	19,434 $906,000
Q3 2020 Nov 13, 2020	SELL	$37.02 - $51.28 $14.6 Million - $20.2 Million	-393,237 Reduced 94.06%	24,855 $1.06 Million
Q2 2020 Aug 12, 2020	BUY	$43.24 - $55.02 $568,562 - $723,457	13,149 Added 3.25%	418,092 $20.1 Million
Q1 2020 May 13, 2020	BUY	$34.37 - $60.07 $5.6 Million - $9.78 Million	162,826 Added 67.25%	404,943 $18.6 Million
Q4 2019 Feb 12, 2020	BUY	$54.32 - $64.31 $410,496 - $485,990	7,557 Added 3.22%	242,117 $14.5 Million
Q3 2019 Nov 12, 2019	BUY	$53.25 - $59.98 $11.5 Million - $13 Million	216,799 Added 1220.65%	234,560 $13.3 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $457,337 - $573,511	9,812 Added 123.44%	17,761 $989,000
Q1 2019 May 14, 2019	BUY	$38.66 - $51.82 $13,646 - $18,292	353 Added 4.65%	7,949 $401,000
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $244,041 - $450,133	-6,646 Reduced 46.66%	7,596 $305,000
Q3 2018 Nov 13, 2018	BUY	$66.65 - $83.86 $100,708 - $126,712	1,511 Added 11.87%	14,242 $987,000
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $184,653 - $276,061	3,603 Added 39.47%	12,731 $963,000
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $48,456 - $62,112	-929 Reduced 9.24%	9,128 $481,000
Q4 2017 Feb 14, 2018	SELL	$49.6 - $60.87 $207,526 - $254,680	-4,184 Reduced 29.38%	10,057 $537,000
Q3 2017 Nov 14, 2017	SELL	$46.62 - $60.36 $275,757 - $357,029	-5,915 Reduced 29.35%	14,241 $850,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,156	20,156 $1.59 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account